| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $3.20M | $1.74M | $1.46M | $2.23M | $2.45M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $321.95M | -$67.65M | -$111.38M | -$60.48M | -$72.92M |
| EPS (basic) | 65.5000 | -21.1000 | -56.2800 | -32.1200 | -39.9500 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |